These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 12601343)

  • 1. Genetic polymorphisms and the progression of liver fibrosis: a critical appraisal.
    Bataller R; North KE; Brenner DA
    Hepatology; 2003 Mar; 37(3):493-503. PubMed ID: 12601343
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Genetic risk factors for hepatic fibrosis in chronic liver diseases].
    Wasmuth HE; Lammert F; Matern S
    Med Klin (Munich); 2003 Dec; 98(12):754-62. PubMed ID: 14685677
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Common heterozygous hemochromatosis gene mutations are risk factors for inflammation and fibrosis in chronic hepatitis C.
    Geier A; Reugels M; Weiskirchen R; Wasmuth HE; Dietrich CG; Siewert E; Gartung C; Lorenzen J; Bosserhoff AK; Brügmann M; Gressner AM; Matern S; Lammert F
    Liver Int; 2004 Aug; 24(4):285-94. PubMed ID: 15287851
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Genetic polymorphisms and liver diseases].
    Bataller R
    Gastroenterol Hepatol; 2003 May; 26(5):307-9. PubMed ID: 12732105
    [No Abstract]   [Full Text] [Related]  

  • 5. [Genome-wide association studies in hepatology].
    Weber S; Grünhage F; Hall R; Lammert F
    Z Gastroenterol; 2010 Jan; 48(1):56-64. PubMed ID: 20072997
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The HFE gene heterozygosis H63D: a cofactor for liver damage in patients with steatohepatitis? Epidemiological and clinical considerations.
    Neri S; Pulvirenti D; Signorelli S; Ignaccolo L; Tsami A; Mauceri B; Misseri M; Interlandi D; Cutuli N; Castellino P
    Intern Med J; 2008 Apr; 38(4):254-8. PubMed ID: 17916170
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HFE mutations, hepatic iron, and fibrosis: ethnic-specific association of NASH with C282Y but not with fibrotic severity.
    Chitturi S; Weltman M; Farrell GC; McDonald D; Kench J; Liddle C; Samarasinghe D; Lin R; Abeygunasekera S; George J
    Hepatology; 2002 Jul; 36(1):142-9. PubMed ID: 12085358
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatic iron overload in patients with chronic viral hepatitis: role of HFE gene mutations.
    Piperno A; Vergani A; Malosio I; Parma L; Fossati L; Ricci A; Bovo G; Boari G; Mancia G
    Hepatology; 1998 Oct; 28(4):1105-9. PubMed ID: 9755249
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HFE mutations in nonalcoholic fatty liver disease.
    Valenti L; Dongiovanni P; Fracanzani AL; Fargion S
    Hepatology; 2008 May; 47(5):1794-5; author reply 1795-6. PubMed ID: 18438784
    [No Abstract]   [Full Text] [Related]  

  • 10. Heterozygosity for hereditary hemochromatosis is associated with more fibrosis in chronic hepatitis C.
    Smith BC; Gorve J; Guzail MA; Day CP; Daly AK; Burt AD; Bassendine MF
    Hepatology; 1998 Jun; 27(6):1695-9. PubMed ID: 9620344
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genomics of liver fibrosis and cirrhosis.
    Osterreicher CH; Stickel F; Brenner DA
    Semin Liver Dis; 2007 Feb; 27(1):28-43. PubMed ID: 17295175
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Iron genes, dysmetabolism and fibrosis in chronic hepatitis C.
    Valenti L; Dongiovanni P; Fargion S; Fracanzani AL
    J Hepatol; 2008 Mar; 48(3):513-4; author reply 514-5. PubMed ID: 18194822
    [No Abstract]   [Full Text] [Related]  

  • 13. Hepatitis C, iron status, and disease severity: relationship with HFE mutations.
    Tung BY; Emond MJ; Bronner MP; Raaka SD; Cotler SJ; Kowdley KV
    Gastroenterology; 2003 Feb; 124(2):318-26. PubMed ID: 12557137
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relative contribution of iron burden, HFE mutations, and insulin resistance to fibrosis in nonalcoholic fatty liver.
    Loria P; Lonardo A; Carulli N
    Hepatology; 2004 Jun; 39(6):1748; author reply 1749. PubMed ID: 15185321
    [No Abstract]   [Full Text] [Related]  

  • 15. Pi*Z heterozygous alpha-1 antitrypsin states accelerate parenchymal but not biliary cirrhosis.
    Cacciottolo TM; Gelson WT; Maguire G; Davies SE; Griffiths WJ
    Eur J Gastroenterol Hepatol; 2014 Apr; 26(4):412-7. PubMed ID: 24518491
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Steatosis is a cofactor in liver injury in hemochromatosis.
    Powell EE; Ali A; Clouston AD; Dixon JL; Lincoln DJ; Purdie DM; Fletcher LM; Powell LW; Jonsson JR
    Gastroenterology; 2005 Dec; 129(6):1937-43. PubMed ID: 16344062
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HFE gene mutations in alcoholic and virus-related cirrhotic patients with hepatocellular carcinoma.
    Lauret E; Rodríguez M; González S; Linares A; López-Vázquez A; Martínez-Borra J; Rodrigo L; López-Larrea C
    Am J Gastroenterol; 2002 Apr; 97(4):1016-21. PubMed ID: 12003382
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence and clinical implications of HFE gene mutations (C282Y and H63D) in patients with chronic hepatitis B and C in Taiwan.
    Mah YH; Kao JH; Liu CJ; Chen CL; Chen PJ; Lai MY; Chen DS
    Liver Int; 2005 Apr; 25(2):214-9. PubMed ID: 15780041
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hemochromatosis gene mutations in patients with alcoholic cirrhosis.
    Starcevic Cizmarevic N; Stepec S; Ristić S; Milić S; Brajenović-Milić B; Stimac D; Kapović M; Peterlin B
    Clin Genet; 2006 Sep; 70(3):257-9. PubMed ID: 16922731
    [No Abstract]   [Full Text] [Related]  

  • 20. Liver iron, HFE gene mutations, and hepatocellular carcinoma occurrence in patients with cirrhosis.
    Nahon P; Sutton A; Rufat P; Ziol M; Thabut G; Schischmanoff PO; Vidaud D; Charnaux N; Couvert P; Ganne-Carrie N; Trinchet JC; Gattegno L; Beaugrand M
    Gastroenterology; 2008 Jan; 134(1):102-10. PubMed ID: 18061182
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.